Logotype for Metagenomi Inc

Metagenomi (MGX) investor relations material

Metagenomi Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Metagenomi Inc
Q2 2025 earnings summary12 Aug, 2025

Executive summary

  • Developing curative gene editing therapeutics with lead programs in hemophilia A and secreted protein deficiencies, and collaborations in cardiometabolic and cell therapy spaces.

  • Advanced MGX-001 hemophilia A program toward pre-IND and ex-U.S. regulatory meetings in 2025, with IND/CTA submission planned for 2026.

  • Showcased early proof-of-concept data for gene editing technologies at ASGCT, including compact nucleases and CAST systems.

  • Collaboration revenue for Q2 2025 was $8.5M, down from $20.0M in Q2 2024, mainly due to the termination of the Moderna agreement and lower Affini-T revenue.

  • Net loss for Q2 2025 was $19.9M, compared to $10.7M in Q2 2024, with a six-month net loss of $44.9M versus $35.9M in the prior year period.

Financial highlights

  • Q2 2025 collaboration revenue: $8.5M (Q2 2024: $20.0M); six months: $12.6M (2024: $31.2M).

  • Q2 2025 R&D expenses: $22.5M (Q2 2024: $28.3M); six months: $47.6M (2024: $59.8M).

  • Q2 2025 G&A expenses: $7.0M (Q2 2024: $8.6M); six months: $13.8M (2024: $17.3M).

  • Net loss per share Q2 2025: $(0.54) (Q2 2024: $(0.29)); six months: $(1.21) (2024: $(1.24)).

  • Cash, cash equivalents, and marketable securities: $205.0M as of June 30, 2025, expected to fund operations into 2027.

Outlook and guidance

  • Cash and marketable securities expected to fund operations into 2027.

  • Plans to conduct pre-IND and ex-U.S. regulatory meetings for MGX-001 in H2 2025, with IND/CTA submissions targeted for 2026.

  • Cardiometabolic collaboration aims for development candidate nomination in 2025.

  • Anticipates increased R&D and G&A expenses as programs advance toward clinical development.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Metagenomi earnings date

Logotype for Metagenomi Inc
Q3 202512 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Metagenomi earnings date

Logotype for Metagenomi Inc
Q3 202512 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Metagenomi Inc. is a biotechnology firm specializing in genetic medicines through its advanced metagenomics-derived genome editing technologies. The company leverages a proprietary toolbox that includes a variety of programmable nucleases, base editors, and RNA and DNA-mediated integration systems. These tools are designed to create precise and curative genetic therapies. Metagenomi focuses on developing these therapies to treat a range of serious diseases by harnessing naturally evolved microbial systems to enhance genome editing capabilities. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage